Impact of biologic and targeted synthetic therapies on bone health in immune-mediated inflammatory diseases: a narrative review
Background Osteoporosis is a systemic skeletal disorder characterized by reduced bone mass, impaired microarchitecture, and increased fracture risk. Patients with immune-mediated inflammatory diseases (IMIDs) have a higher prevalence of osteoporosis owing to chronic inflammation, glucocorticoid use, and disease-specifi...